St. Jude Medical, Inc. (STJ) Tops Q3 EPS by 2c; Guides Q4 Below the Street
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts STJ Hot Sheet
Join SI Premium – FREE
St. Jude Medical, Inc. (NYSE: STJ) reported Q3 EPS of $0.78, $0.02 better than the analyst estimate of $0.76. Revenue for the quarter came in at $1.38 billion versus the consensus estimate of $1.37 billion.
St. Jude Medical, Inc. sees Q4 2011 EPS of $0.83-$0.85, versus the consensus of $0.86.
St. Jude Medical, Inc. sees Q4 2011 EPS of $0.83-$0.85, versus the consensus of $0.86.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boston Beer Co. (SAM) Tops Q3 EPS by 15c; offers guidance
- First Hawaiian (FHB) Misses Q3 EPS by 7c
- American Express (AXP) Tops Q3 EPS by 84c, Misses on Revenue, Raises FY Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
